FSI Stanford Events

Assessing the Costs and Benefits of Screening for HIV

CHP/PCOR Research in Progress Seminar

Date and Time
November 16, 2005
1:30 PM - 3:00 PM

Availability
Open to the public
No RSVP required

Speakers
Swati Tole - Stanford University
DK Owens

Location
Health Research & Policy Building
(Redwood Building), Room T138-B
259 Campus Drive
Stanford University
Stanford, CA 94305
» Directions/Map

FSI Contact
Sara L. Selis

Parent Research Projects

Evaluating the Cost and Benefits of Potential Preventive and Therapeutic HIV Vaccines
DK Owens
The Benefits and Costs of Health Plan Choice: The Case of Medicare Part D Prescription Drug Plans
M. Kate Bundorf
Vaccinate Early and Often: Health Benefits and Costs of Pandemic Response Strategies for Pandemic (H1N1) 2009 and Influenza A (H5N1, or "Avian Flu")
Douglas K. Owens, Alan M. Garber, David Hutton, Nayer Khazeni
The HIV Testing Masquerade: Concealing an Interest to Test for HIV
Sean Young

When Women Return to Risk: Costs and Benefits of HIV Screening in the Presence of Relapse
Margaret L. Brandeau, Douglas K. Owens
Raven Press (New York) in "Modeling the AIDS Epidemic: Planning, Policy and Prediction", Kaplan EH, Brandeau ML, eds. (1994)
Expanded HIV Screening in the United States: Effect on Clinical Outcomes, HIV Transmission, and Costs
A. David Paltiel, RP Walensky, BR Schackman, GR Seage, LM Mercincavage, MC Weinstein, KA Freedberg
Annals of Internal Medicine vol. 145, 11 (2006)
Costs and Benefits of Prenatal Screening for Cystic Fibrosis
Alan M. Garber, J.P Fenerty
Medical Care vol. 29 (1991)
Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use
Douglas K. Owens, D.M. Edward, Ross D. Shachter
Yale Press in "Quantitative Evaluation of HIV Prevention Programs", Kaplan EH, Brookmeyer R, eds. (2001)